WVEWave Life Sciences Ltd.

$3B

Q3 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$8M+199.1% YoY

Gross Profit

$8M100.0% margin

Operating Income

-$56M-740.7% margin

Net Income

-$54M-707.8% margin

EPS (Diluted)

$-0.32

QoQ Revenue Growth

-12.5%

Cash Flow

Operating Cash Flow

-$45M

Free Cash Flow

-$45M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$241M

Total Liabilities

$117M

Stockholders' Equity

$125M

Cash & Equivalents

$196M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	-$8M	+199.1%
Gross Profit	$8M	-$8M	+199.1%
Operating Income	-$56M	-$64M	+11.8%
Net Income	-$54M	-$62M	+12.8%

WVE Q3 2025 Earnings — Wave Life Sciences Ltd. Revenue & Financial Results | Market Cap Arena